Skip to main content

Featured Content

Public health risk is forcing addiction treatment programs to rethink their typical approaches to patient drug testing at this time.
A longer duration of treatment with the injectable formulation of buprenorphine for opioid use disorder was associated with more favorable abstinence outcomes in a newly published study.
Two addiction treatment leaders discuss the industrywide disruption from the COVID-19 crisis and how it is affecting the psyche of providers and patients.
As the U.S. population ages, Elisha Figueroa, LMSW, CPS, and Angie Jones, MSSW, of JBS International say prevention professionals will need to sharpen the focus of their messaging when working with older adults.
The Trevor Project states that a higher prevalence of substance use in the LGBT youth and young-adult populations calls for a greater focus on this issue in prevention and research.

Meetings & Publications

Back to Top